| First Author | Jennings RT | Year | 2014 |
| Journal | Blood | Volume | 123 |
| Issue | 23 | Pages | 3635-45 |
| PubMed ID | 24782506 | Mgi Jnum | J:211293 |
| Mgi Id | MGI:5574407 | Doi | 10.1182/blood-2014-02-557843 |
| Citation | Jennings RT, et al. (2014) RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness. Blood 123(23):3635-45 |
| abstractText | Neutrophil responses are central to host protection and inflammation. Neutrophil activation follows a 2-step process in which priming amplifies responses to activating stimuli. Priming is essential for life span extension, chemotaxis, and respiratory burst activity. Here we show that the cytoskeletal organizer RhoA suppresses neutrophil priming via formins. Premature granule exocytosis in Rho-deficient neutrophils activated numerous signaling pathways and amplified superoxide generation. Deletion of Rho altered front-to-back coordination by simultaneously increasing uropod elongation, leading edge formation, and random migration. Concomitant negative and positive regulation of beta2 integrin-independent and beta2 integrin-dependent migration, respectively, reveal Rho as a key decision point in the neutrophil response to discrete chemotactic agents. Although even restricted influx of Rho-deficient hyperactive neutrophils exacerbated lipopolysaccharide-mediated lung injury, deleting Rho in innate immune cells was highly protective in influenza A virus infection. Hence, Rho is a key regulator of disease progression by maintaining neutrophil quiescence and suppressing hyperresponsiveness. |
